Scadden David
CIK 0001707715
Director
Filings
19
Latest Nov 14, 2025
Issuers covered
4
Showing
19 of 19
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 83% | +11.2% | +7.9% | +37.5% | -7.6% |
| 90 days | 6 | 83% | +25.2% | +30.0% | +37.8% | -7.8% |
| 180 days | 6 | 100% | +26.1% | +24.7% | +35.8% | +18.3% |
| 365 days | 1 | 100% | +36.7% | +36.7% | +36.7% | +36.7% |
Issuers
Companies where Scadden David has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals, Inc. | 13 | Nov 14, 2025 |
| EDIT | Editas Medicine, Inc. | 4 | Jun 10, 2025 |
| CARM | Carisma Therapeutics Inc. | 1 | Jul 1, 2024 |
| DNTH | Dianthus Therapeutics, Inc. /De/ | 1 | Jun 30, 2022 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|